Predictive Medicine in Pharmaceutical Analysis

Predictive medicine is a field of medicine that entails predicting the probability of disease and instituting preventive measures in order to either prevent the disease altogether or significantly decrease its impact upon the patient (such as by preventing mortality or limiting morbidity). Techniques and assays include Newborn screening, Diagnostic testing, Medical bioinformatics, Prenatal testing, Carrier testing, Preconception testing. Newborn screening is a public health program designed to screen infants shortly after birth for a list of conditions that are treatable, but not clinically evident in the newborn period. Prenatal testing: Prenatal testing is used to look for diseases and conditions in a fetus or embryo before it is born. This type of testing is offered for couples who have an increased risk of having a baby with a genetic or chromosomal disorder. Screening can determine the sex of the fetus. Prenatal testing can help a couple decide whether to abort the pregnancy. Like diagnostic testing, prenatal testing can be noninvasive or invasive. Non-invasive techniques include examinations of the woman's womb through ultrasonography or maternal serum screens. These non-invasive techniques can evaluate risk of a condition, but cannot determine with certainty if the fetus has a condition.
  • Techniques and Assays
  • Drug designing in Personalized Medicine
  • Newborn screening, Prenatal testing

Related Conference of Predictive Medicine in Pharmaceutical Analysis

Predictive Medicine in Pharmaceutical Analysis Conference Speakers